Herantis Pharma Oyj (HEL:HRTIS)

Herantis Pharma Oyj Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.75	0.63	5.5	5.04	6.44
Short-Term Investments	1.85	1.5	0.99	0.96	0.99
Cash & Short-Term Investments	2.6	2.13	6.49	5.99	7.42
Cash Growth	21.67%	-67.10%	8.30%	-19.31%	-44.28%
Other Receivables	0.04	0.41	0.24	0.2	0.12
Receivables	0.04	0.41	0.24	0.2	0.12
Prepaid Expenses	0.04	0.03	0.02	0.04	0.06
Other Current Assets	-0	-	-	-	-
Total Current Assets	2.67	2.57	6.75	6.23	7.6
Long-Term Deferred Charges	-	-	-	-	0.16
Total Assets	2.67	2.57	6.75	6.23	7.76
Accounts Payable	0.39	0.28	0.75	0.66	0.79
Accrued Expenses	0.49	0.28	1.17	1.06	0.73
Current Portion of Long-Term Debt	0.01	0	0	0.15	0.91
Current Portion of Leases	-	0.04	-	-	0.13
Other Current Liabilities	0.03	0.03	0.06	0.03	0.05
Total Current Liabilities	0.91	0.63	1.99	1.9	2.61
Long-Term Debt	0.02	0.02	0.03	4.39	6.29
Other Long-Term Liabilities	3.42	2.16	-	-	0
Total Liabilities	4.36	2.81	2.02	6.29	8.9
Common Stock	0.08	0.08	0.08	0.08	0.08
Retained Earnings	-86.71	-80.07	-75.1	-75.38	-67.75
Comprehensive Income & Other	84.94	79.75	79.75	75.24	66.53
Shareholders' Equity	-1.69	-0.24	4.73	-0.06	-1.14
Total Liabilities & Equity	2.67	2.57	6.75	6.23	7.76
Total Debt	0.03	0.07	0.03	4.54	7.33
Net Cash (Debt)	2.57	2.06	6.45	1.45	0.09
Net Cash Growth	24.82%	-68.07%	345.14%	1482.98%	-98.50%
Net Cash Per Share	0.11	0.10	0.38	0.10	0.01
Filing Date Shares Outstanding	24.09	20.16	20.16	16.91	11.1
Total Common Shares Outstanding	24.09	20.16	20.16	16.91	11.1
Working Capital	1.76	1.94	4.76	4.33	4.99
Book Value Per Share	-0.07	-0.01	0.23	-0.00	-0.10
Tangible Book Value	-1.69	-0.24	4.73	-0.06	-1.14
Tangible Book Value Per Share	-0.07	-0.01	0.23	-0.00	-0.10

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.